WO1997037672A1 - Preparation biosynthetique poudreuse se composant de bois de rennes ossifies, et additif alimentaire a base de cette preparation biosynthetique - Google Patents

Preparation biosynthetique poudreuse se composant de bois de rennes ossifies, et additif alimentaire a base de cette preparation biosynthetique Download PDF

Info

Publication number
WO1997037672A1
WO1997037672A1 PCT/RU1996/000225 RU9600225W WO9737672A1 WO 1997037672 A1 WO1997037672 A1 WO 1997037672A1 RU 9600225 W RU9600225 W RU 9600225W WO 9737672 A1 WO9737672 A1 WO 9737672A1
Authority
WO
WIPO (PCT)
Prior art keywords
mcg
мыши
mkg
less
κιοβ
Prior art date
Application number
PCT/RU1996/000225
Other languages
English (en)
Russian (ru)
Inventor
Vladimir Vladimirovich Tsygankov
Original Assignee
Tsygankov Vladimir Vladimirovi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsygankov Vladimir Vladimirovi filed Critical Tsygankov Vladimir Vladimirovi
Publication of WO1997037672A1 publication Critical patent/WO1997037672A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/34—Animal material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the family has the following;: an artist! organic matter 75 '. wt. inorganic materials 25 ". wt., where the nitrogen: yellow ⁇ , 3 wt. 7. bulk 0.15 wt. 7. ⁇ proteins 52.7 wt.% LIQUID 5.6 wt. 7. C mono- and disakhara 15.5 wt. 7. ash 25.0 wt. 7.
  • FIRST AND PANTOKRIN contains a significant number of mak- ⁇ and microelements (Ca, Na, S, Si, ⁇ , ⁇ 1, ⁇ réelle, ⁇ , ⁇ , ⁇ , ⁇ '), which pre-occupies the environment. 35
  • the main bulk of the active material of the pantocrin is the lipid fraction and the most important of the phospholipids are the viral bases - choline and ethanolamine.
  • the drug is delivered by a special liquid extract (151 v ⁇ n_ panels of males of the northern deer, obtained by 40 "/. Russia, Foreign Publishing House, 1 ° 78).
  • Such a payload, payload and pantokrin are not released only in the form of BLOOD EXTRACTS, but in the form of a silent, where the active case is called * ect.
  • ⁇ a significant measure on the activity of the extracts from the panels is influenced by the tee ;: a nullogy of the inconsequence of the last;, the medicine
  • the foodstuffs ⁇ _ are known (nutritives, naturopathic drugs), containing biologically active products, which are of interest to:; biologically active :: substances,
  • the protection principle of the claimed invention is ⁇ -. ⁇ aznyi ''! ..genic erythropoietin, essentially, essentially:
  • the original product contains, in the main! lipids 0, 13-0.25 wt. 7. amino acids and peptides less than 0, ⁇ 0 mg / g, cholesterol 0.10-0.20 mg / g
  • ⁇ ⁇ is less than ⁇ measure 3.5 wt. 7. Calcium 15.0-20.0 wt. 7. iodine 0.02-0.04 wt. * /. magnes .'- ⁇ to 6800 mkg / g
  • n ⁇ vy yi ⁇ gennyS ⁇ e ⁇ a ⁇ a ⁇ , ⁇ eds ⁇ avlyayuschy s ⁇ _. ⁇ _ ⁇ ⁇ sh ⁇ _. ⁇ azny ⁇ du ⁇ , ⁇ IS ⁇ Y ⁇ chas ⁇ itsy ⁇ imeyu ⁇ DIS ⁇ S ⁇ S ⁇ , s ⁇ s ⁇ avl guide in ⁇ sn ⁇ vi ⁇ m - g 80 ° ⁇ lme ⁇ n ⁇ "/.- less than 0.25 mm udeln ⁇ S ⁇ ⁇ ve ⁇ n ⁇ s ⁇ yu ⁇ l ⁇ 100 m 3 / g and The volume is 3.0 m ⁇ / g, is derived from the history of the deer, and the name of the deer, the deer, the deer, the forest, and the European deer.
  • S ⁇ de ⁇ _aiye y ⁇ da for example, in the form of ydiradiamine warfare ⁇ -derivative: amino acids tyrosine ( ⁇ , ⁇ ,
  • the content is heavy ;: toxic metals (lead, yadmihmi, KUI, moly-.den, a great amount of g and other) are in good condition, but are not subject to increased stress.
  • Toxic Metals.
  • the data we have received are indicative of the fact that there are significant differences in the number of components; they are original ;; original ;; ⁇ e ⁇ a ⁇ a ⁇ v of ⁇ s ⁇ enely: ⁇ ⁇ l ⁇ ne ⁇ '" ⁇ azn ⁇ g' ⁇ kind U ⁇ U ⁇ m ⁇ ala, izyub ⁇ a, ⁇ ya ⁇ nis ⁇ g ⁇ ⁇ lenya or ⁇ lenya seve ⁇ n ⁇ g ⁇ D ⁇ s ⁇ ignu ⁇ ye ⁇ izi ⁇ - :: imiches ⁇ ie and ⁇ gan ⁇ le ⁇ iches ⁇ ie ⁇ azageli ⁇ aches ⁇ va zayavlyaem ⁇ g ⁇ ⁇ sh ⁇ .. ⁇ azn ⁇ g ⁇
  • the device eliminates the need for development of a patient in the process of taking the gland to the stage :; electronic spanning pan. This is a purely respectable and superficial survey.
  • the drug is water-soluble, it is not toxic for human cells, the adhesive properties of the battery increase with a decrease in the dose of the drug.
  • the drug is delivered with expressed and effective effects, with a decrease in the dose of 5, the result is a negative response.
  • Doses of 0, 1 mcg ml were found to be 3 times the dose, doses of 1 mcg to 2 times and a dose of 5 mcg / ml to 1.5 times.
  • Doses of 10 and 50 ⁇ g ml did not affect the ⁇ or ⁇ rative response. ⁇ The latter has observed the effect of enhancing the synthesis of the Christmas tree. ⁇ Domino ⁇ ire ⁇
  • Dosage preparation 0.1-0.001 mcg / ml does not affect the human ex- perience of the human antigens.
  • Lipid the concentration increased in ⁇ ⁇ - > ⁇ and there are also kalesters and t-glycides. 20 For evaluating the Christmas exchange, they shared ⁇ / ⁇ __ business
  • the functional liver of the liver was evaluated in the content of the text ⁇ AND ⁇ general ⁇ . Or ⁇ in-, ⁇ and ⁇ . 25 0 s ⁇ s ⁇ yani ⁇ CBE ⁇ yvayusche ⁇ ' ⁇ and ⁇ iv ⁇ sve ⁇ yvayuschey sis ⁇ en ⁇ I judged on ⁇ sn ⁇ vanii ⁇ edeleniya ⁇ CH ⁇ ⁇ YI ⁇ I ⁇ - d ⁇ sa ⁇ vi ⁇ a, ⁇ iB ⁇ i ⁇ gena ⁇ r ⁇ u ⁇ d ⁇ ' ⁇ ee ha and ⁇ IY ⁇ I ⁇ LI- ⁇ iches ⁇ S ⁇ Y ⁇ S ⁇ '. ⁇ ⁇ ⁇ ⁇ zi ⁇ ⁇ eg ⁇ d ⁇ ⁇ vals ⁇ g ⁇ , and ⁇ s ⁇ e ⁇ a ⁇ lve ⁇ soon.
  • CDS superacid acididase
  • the concentration of immunogloeulin ⁇ in ⁇ , ⁇ , ⁇ , components of the S3, C4 component was divided by the immunochemical method for analysis of "C5- ⁇ , Beckman, S. 30 ALL RESEARCH LIVED ⁇ dynamics to evaluate the impact of alimentary intervention.
  • ⁇ ⁇ ⁇ ⁇ tsesse ⁇ vsednevn ⁇ g ⁇ ⁇ lin ⁇ ches ⁇ g ⁇ naolyudeniya for O ⁇ L ⁇ Y ⁇ I in ⁇ e ⁇ d ⁇ liniches ⁇ i ⁇ is ⁇ y ⁇ any any ⁇ dn ⁇ m sl ⁇ chae not _.yl ⁇ za ⁇ egis ⁇ i ⁇ van ⁇ ⁇ a ⁇ i ⁇ -lib ⁇ phenomena ne ⁇ e ⁇ en ⁇ si- 35 m ⁇ s ⁇ i e ⁇ y ⁇ ischev ⁇ S ⁇ d ⁇ eav ⁇ i or alle ⁇ giches ⁇ i ⁇ ⁇ ea ⁇ tsiSl.
  • Tortured antioxidant activity of an addictive substance can be, in part, if there is a risk of physical inactivity in it, there is a risk for it.
  • the dynamics of the indicators of the P / 1 system is anti-oxidative protection by interfering with the declared claim of PI_Ie_- ⁇ _' ⁇ before the occurrence of cardiomyopathy in the USA.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Cette invention concerne une préparation biosynthétique poudreuse se composant de bois de rennes ossifiés. Cette préparation est obtenue en broyant le produit de base de manière à obtenir des particules d'une taille inférieure à 0,25 mm, et une surface spécifique qui soit approximativement de 100 m2/g, les pores des particules représentant environ 3,0 m2/g. Cette invention concerne également un additif alimentaire qui comprend, en qualité d'agent biologique actif, cette préparation biosynthétique poudreuse se composant de bois de rennes ossifiés.
PCT/RU1996/000225 1996-04-11 1996-08-08 Preparation biosynthetique poudreuse se composant de bois de rennes ossifies, et additif alimentaire a base de cette preparation biosynthetique WO1997037672A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU96106596/14A RU2077887C1 (ru) 1996-04-11 1996-04-11 Порошкообразный биогенный препарат из окостенелых оленьих рогов и пищевая добавка на его основе
RU96106596 1996-04-11

Publications (1)

Publication Number Publication Date
WO1997037672A1 true WO1997037672A1 (fr) 1997-10-16

Family

ID=20178947

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU1996/000225 WO1997037672A1 (fr) 1996-04-11 1996-08-08 Preparation biosynthetique poudreuse se composant de bois de rennes ossifies, et additif alimentaire a base de cette preparation biosynthetique

Country Status (5)

Country Link
CA (1) CA2201768A1 (fr)
FI (1) FI971481A (fr)
RU (1) RU2077887C1 (fr)
SE (1) SE9701278L (fr)
WO (1) WO1997037672A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1579865A1 (fr) * 2002-12-20 2005-09-28 Vladimir Vladimirovich Tsygankov Moyen de prevention et de traitement de perturbations du systeme endocrinien

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2213568C1 (ru) * 2002-10-17 2003-10-10 Цыганков Владимир Владимирович Фармацевтическая композиция и противодиабетическое средство на ее основе
RU2236239C1 (ru) * 2003-07-03 2004-09-20 Цыганков Владимир Владимирович Фармацевтическая композиция для лечения и профилактики патологических состояний, связанных с недостатком эндорфинов в организме
RU2352331C1 (ru) * 2007-07-04 2009-04-20 Владислав Николаевич Ласкавый Средство, обладающее холестеринорегулирующим действием
RU2519727C2 (ru) * 2011-11-23 2014-06-20 Общество с ограниченной ответственностью "Биолит" (ООО "Биолит") Антипролиферативное средство

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634948B1 (fr) * 1992-08-06 1993-03-04
RU2031927C1 (ru) * 1992-09-29 1995-03-27 Научно-исследовательский институт фармакологии Томского научного центра РАМН Композиция ингредиентов для полусладкой настойки
SU1783645A1 (ru) * 1989-12-06 1995-09-27 Г.Я. Брызгалов Способ получения экстракта рогов северного оленя
RU2054292C1 (ru) * 1992-11-25 1996-02-20 Сергей Николаевич Ларцев Способ получения биологически активных веществ из пантов

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1783645A1 (ru) * 1989-12-06 1995-09-27 Г.Я. Брызгалов Способ получения экстракта рогов северного оленя
AU634948B1 (fr) * 1992-08-06 1993-03-04
RU2031927C1 (ru) * 1992-09-29 1995-03-27 Научно-исследовательский институт фармакологии Томского научного центра РАМН Композиция ингредиентов для полусладкой настойки
RU2054292C1 (ru) * 1992-11-25 1996-02-20 Сергей Николаевич Ларцев Способ получения биологически активных веществ из пантов

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1579865A1 (fr) * 2002-12-20 2005-09-28 Vladimir Vladimirovich Tsygankov Moyen de prevention et de traitement de perturbations du systeme endocrinien
EP1579865A4 (fr) * 2002-12-20 2009-06-24 Tsygankov Vladimir Vladimirovi Moyen de prevention et de traitement de perturbations du systeme endocrinien

Also Published As

Publication number Publication date
CA2201768A1 (fr) 1997-10-11
RU2077887C1 (ru) 1997-04-27
FI971481A0 (fi) 1997-04-09
SE9701278D0 (sv) 1997-04-08
SE9701278L (sv) 1997-10-12
FI971481A (fi) 1997-10-12

Similar Documents

Publication Publication Date Title
WO1989011284A1 (fr) Composition empechant le developpement de l'attirance pathologique pour l'alcool
RU2491083C2 (ru) Применение фитоэкдизонов и получение композиции для воздействия на метаболический синдром
WO1995022336A1 (fr) Agent immunomodulateur et reducteur du dysfonctionnement du systeme de regulation de la propagation de cellules tissulaires
WO1995017902A1 (fr) Utilisation d'une souche du champignon fusarium comme producteur de substances et preparation a base celle-ci presentant, des proprietes, adaptogeniques et immunomodulatrices
WO2002091860A1 (fr) Additif alimentaire biologiquement actif et additif fourrager biologiquement actif servant a prevenir la carence en iode et a optimiser le metabolisme de l'iode, produits alimentaires et fourragers contenant ces additifs
WO1997037672A1 (fr) Preparation biosynthetique poudreuse se composant de bois de rennes ossifies, et additif alimentaire a base de cette preparation biosynthetique
RU2283124C1 (ru) Биологически активный препарат на основе морского растительного сырья
Khan et al. A Review-Benefits of Panchgavya therapy (Cowpathy) for health of humans
KR20200043555A (ko) 다이어트용 보조식품 조성물
CN105454601A (zh) 黑青稞减肥茶（奶茶）
Alkhateeb Evaluation of antidiabetic, antioxidant and antilipidemic potential of natural dietary product prepared from Cyphostemma digitatum in rats’ model of diabetes
JP2003002836A (ja) レムナントリポ蛋白低減剤及び機能性食品
CN108991358A (zh) 一种辅助降血脂、降血糖、缓解痛风保健食品及生产方法
HIELM‐BJÖRKMAN et al. Panax Ginseng in combination with brewers’ yeast (Gerivet®) as a stimulant for geriatric dogs: a controlled‐randomized blinded study
Pozdnyakova et al. Antioxidant Phytocomplex with Antitumor Activity
KR20030087383A (ko) 효모벽 추출물의 베타-글루칸을 이용한 건강증진 방법
RU2475050C2 (ru) Композиция веществ для воздействия на микробно-тканевой комплекс кишечника человека "протобиол" и способ восстановления микробно-тканевого комплекса в целом
Enders Gut Fit-Fat Gone
Jukes Megavitamins and food fads
WO1985003848A1 (fr) Produit lacte acidifie
Zarapovna et al. Detoxication issues in sports Medicine
Bisht et al. Recent Progression Of Chromium And Its Salts For Combating In Kinds Of Human Metabolic Disorder And Diseases
Mokhtar et al. Effect of Watermelon Rind Powder on Gut Microbiome and Weight Loss in Obese Rats.
Vahidi et al. Serum zinc levels in children with growth failure in Kerman province, Iran
WO2020029221A1 (fr) Composition à inhibition de la formation de graisse et activités antioxydantes et son utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): BG BY CA CN EE HU IS JP KP KR LV MN NO PL SG SI SK UA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97536106

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA